Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials (June 2023) Insufficient Sleep Predicts Poor Weight Loss Maintenance After 1 Year (May 2023) Stress and Obesity (January 2019) Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) The Effect of Semaglutide 2.4 mg Once Weekly on Energy Intake, Appetite, Control of Eating, and Gastric Emptying in Adults With Obesity (March 2021) Efficacy and Safety of Semaglutide for Weight Management: Evidence From the STEP Program (April 2022)
It's built for a specific type of buyer
Lower the risk of major cardiovascular events, including heart attack, stroke, or death, in adults with type 2 diabetes who have established heart disease
Our bestselling serum uses copper peptides alongside hyaluronic, polyglutamic, and sugarcane-derived squalane to visibly improve the look of fine lines and wrinkles
Heise T, DeVries JH, Urva S et al (2023) Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes
La ricerca preclinica ha rivelato un ampio spettro di attivit biologiche, tra cui la citoprotezione gastrica, la modulazione della via dell'ossido nitrico (NO) e l'interazione con il sistema dopaminergico
